Your browser doesn't support javascript.
loading
Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older.
Wolfe, Daniel N; Espeland, Eric M; Gao, Yonghong; Lu, Di; Blatner, Gretta; Amass, Kathryn; Horwith, Gary; Tong, Xiaomi M; Hopkins, Robert; David, Gloria L; Jepson, Brett M; King, James C.
Afiliación
  • Wolfe DN; Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority, Washington, DC, United States. Electronic address: daniel.wolfe2@hhs.gov.
  • Espeland EM; Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Gao Y; Division of Clinical Development, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Lu D; Division of Clinical Development, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Blatner G; Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Amass K; Division of Clinical Development, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Horwith G; Division of Clinical Development, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Tong XM; Regulatory and Quality Affairs Division, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • Hopkins R; Division of Clinical Development, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
  • David GL; Rho Federal Systems Division, Durham, NC, United States.
  • Jepson BM; Rho Federal Systems Division, Durham, NC, United States.
  • King JC; Division of Clinical Development, Biomedical Advanced Research and Development Authority, Washington, DC, United States.
Vaccine ; 38(50): 7970-7976, 2020 11 25.
Article en En | MEDLINE | ID: mdl-33129609
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Carbunco / Carbunco Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Carbunco / Carbunco Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article